DellaFeliceMakowerMD
Oncology • White Plains, NYAssistant Professor, Medicine, Oncology, Albert Einstein College of Medicine
Dr. Makower is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Longview Ave
Ste 201
White Plains, NY 10601Phone+1 914-684-2779Fax+1 914-684-6859
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 1995 - 1996
Jacobi Medical Center/Albert Einstein College of MedicineFellowship, Hematology and Medical Oncology, 1993 - 1995
NYU Grossman School of MedicineResidency, Internal Medicine, 1990 - 1993- New York University School of MedicineClass of 1990
Certifications & Licensure
NY State Medical License 1991 - 2026- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia Start of enrollment: 1999 Aug 11
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
- Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI Start of enrollment: 2013 May 31
- Join now to see all
Publications & Presentations
PubMed
- 1318 citationsAdjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerJoseph A. Sparano, Robert Gray, Della F. Makower, Kathleen I. Pritchard, Kathy S. Albain
The New England Journal of Medicine. 2018-06-03 - 69 citationsRace, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx TrialKathy S. Albain, Robert Gray, Della F. Makower, Amir Faghih, Daniel F. Hayes
Journal of the National Cancer Institute. 2021-04-06 - 76 citationsRandomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuva...Ingrid A. Mayer, Fengmin Zhao, Carlos L. Arteaga, William Fraser Symmans, Ben Ho Park
Journal of Clinical Oncology. 2021-06-06
Journal Articles
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerMatthew P Goetz, Thomas J Saphner, Joseph A Sparano, Lynne I Wagner, Peter M Ravdin, Daniel F Hayes, Adam M Brufsky, Della F Makower, Sunil S Badve, Robert J Gray, Wil..., The New England Journal of Medicine
Press Mentions
Recent Advances in Neoadjuvant Therapy for Breast CancerJanuary 4th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
